CD4 and Parkinson disease: PD patients also experience the disruption of the BBB, allowing peripheral CD4+ T-cells to infiltrate the brain and potentially affect other mechanisms related to neurodegeneration, such as oxidative stress and mitochondrial dysfunction [106].